Cargando…

OR25-06 Morning ACTH Levels as a Reliable Biomarker for Excluding Autonomous Cortisol Secretion in Incidetally Discovered Adrenal Adenomas. A Prospective Cohort

Adrenal incidentalomas are common with a prevalence of 3-10% and in up to 30% of cases may have probable autonomous cortisol secretion. Hypercortisolism is associated with substantial cardiometabolic morbimortality and can physiologically decrease ACTH levels. Objective: To determine the sensitivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Olmos, Roberto Ignacio, Macchiavello, Stefano Pietro, Vaidya, Anand, Robles, Consuelo, Gutierrez, Javiera, Guarda, Francisco J, Francisco, Ignacio San, Huete, Alvaro, Baudrand, Rene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207414/
http://dx.doi.org/10.1210/jendso/bvaa046.1308
_version_ 1783530599662747648
author Olmos, Roberto Ignacio
Macchiavello, Stefano Pietro
Vaidya, Anand
Robles, Consuelo
Gutierrez, Javiera
Guarda, Francisco J
Francisco, Ignacio San
Huete, Alvaro
Baudrand, Rene
author_facet Olmos, Roberto Ignacio
Macchiavello, Stefano Pietro
Vaidya, Anand
Robles, Consuelo
Gutierrez, Javiera
Guarda, Francisco J
Francisco, Ignacio San
Huete, Alvaro
Baudrand, Rene
author_sort Olmos, Roberto Ignacio
collection PubMed
description Adrenal incidentalomas are common with a prevalence of 3-10% and in up to 30% of cases may have probable autonomous cortisol secretion. Hypercortisolism is associated with substantial cardiometabolic morbimortality and can physiologically decrease ACTH levels. Objective: To determine the sensitivity, specificity, and positive and negative predictive values of ACTH levels in evaluating autonomous cortisol secretion in a prospective cohort of incidentally discovered adrenal adenomas. Methods: We prospectively evaluated 224 consecutive adult subjects with incidentally discovered adrenal masses on computed tomography. Finally, 168 participants with radiographic adenoma criteria underwent systematic hormonal assessment, including measurements of morning cortisol and ACTH on day 1, and a 1 mg dexamethasone suppression test (DST) on day 2. Hypercortisolism was excluded if the DST was < 1.8 mcg/dL. Autonomous cortisol secretion was defined as a DST > 5.0 mcg/dL and DST levels of 1.8-5.0 mcg/dL were considered to be possibly autonomous hypercortisolism. We evaluated the correlation of ACTH levels with clinical, radiographic, and endocrine variables. In order to identify the most sensitive threshold value for diagnosing autonomous cortisol secretion, we determined ROC curves and negative likelihood ratio (NLR). Concordance of repeated ACTH was assessed using Bland Altman analysis. Results: The characteristics of the cohort were mean age 56 (+/- 11.8) years, 76% female, adenoma size 19 (+/- 7) mm, and 13% bilateral adenomas. Mean ACTH was 15 (+/- 11) pg/ml (range 5-72) and the mean DST was 2.2 (+/- 3.0) ug/dL (range 0.4-25.9). Fifty-four (32%) participants had a DST ≥1.8mcg/dL and 13 (8%) a DST≥5.0 mcg/dL. We found no correlation between ACTH levels and age, gender or body mass index. ACTH was inversely associated with adrenal adenoma diameter (r=-3.3 p=0.002) and volume (r=-2.9 p=0.008). There was an inverse association between ACTH and DST values (r=-3.1 p=0.01). In the subgroup of patients with a second ACTH measurement we found high concordance, with mean difference of 0.16+/-3.6 pg/ml (p=0.83). ROC analysis showed that an ACTH ≥20 pg/ml had a sensitivity of 98% to exclude hypercortisolism, with a negative predictive value of 97% and a negative likelihood ratio of 0.06. The only case with DST≥1.8 and ACTH≥20 had Cushing′s phenotype with both an adrenal adenoma and a pituitary ACTH-producing adenoma. Systematic evaluation of morning cortisol and ACTH allowed the detection of 5 cases of false negative low DST values due to the use of non-oral corticosteroids. Conclusion: In this cohort, an ACTH ≥20pg/ml excluded autonomous cortisol secretion with excellent sensitivity and negative predictive value, providing strong reassurance that there is no clinically relevant hypercortisolism. Therefore, subjects with a normal DST and ACTH ≥20pg/ml should be candidates for relaxed surveillance.
format Online
Article
Text
id pubmed-7207414
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72074142020-05-13 OR25-06 Morning ACTH Levels as a Reliable Biomarker for Excluding Autonomous Cortisol Secretion in Incidetally Discovered Adrenal Adenomas. A Prospective Cohort Olmos, Roberto Ignacio Macchiavello, Stefano Pietro Vaidya, Anand Robles, Consuelo Gutierrez, Javiera Guarda, Francisco J Francisco, Ignacio San Huete, Alvaro Baudrand, Rene J Endocr Soc Adrenal Adrenal incidentalomas are common with a prevalence of 3-10% and in up to 30% of cases may have probable autonomous cortisol secretion. Hypercortisolism is associated with substantial cardiometabolic morbimortality and can physiologically decrease ACTH levels. Objective: To determine the sensitivity, specificity, and positive and negative predictive values of ACTH levels in evaluating autonomous cortisol secretion in a prospective cohort of incidentally discovered adrenal adenomas. Methods: We prospectively evaluated 224 consecutive adult subjects with incidentally discovered adrenal masses on computed tomography. Finally, 168 participants with radiographic adenoma criteria underwent systematic hormonal assessment, including measurements of morning cortisol and ACTH on day 1, and a 1 mg dexamethasone suppression test (DST) on day 2. Hypercortisolism was excluded if the DST was < 1.8 mcg/dL. Autonomous cortisol secretion was defined as a DST > 5.0 mcg/dL and DST levels of 1.8-5.0 mcg/dL were considered to be possibly autonomous hypercortisolism. We evaluated the correlation of ACTH levels with clinical, radiographic, and endocrine variables. In order to identify the most sensitive threshold value for diagnosing autonomous cortisol secretion, we determined ROC curves and negative likelihood ratio (NLR). Concordance of repeated ACTH was assessed using Bland Altman analysis. Results: The characteristics of the cohort were mean age 56 (+/- 11.8) years, 76% female, adenoma size 19 (+/- 7) mm, and 13% bilateral adenomas. Mean ACTH was 15 (+/- 11) pg/ml (range 5-72) and the mean DST was 2.2 (+/- 3.0) ug/dL (range 0.4-25.9). Fifty-four (32%) participants had a DST ≥1.8mcg/dL and 13 (8%) a DST≥5.0 mcg/dL. We found no correlation between ACTH levels and age, gender or body mass index. ACTH was inversely associated with adrenal adenoma diameter (r=-3.3 p=0.002) and volume (r=-2.9 p=0.008). There was an inverse association between ACTH and DST values (r=-3.1 p=0.01). In the subgroup of patients with a second ACTH measurement we found high concordance, with mean difference of 0.16+/-3.6 pg/ml (p=0.83). ROC analysis showed that an ACTH ≥20 pg/ml had a sensitivity of 98% to exclude hypercortisolism, with a negative predictive value of 97% and a negative likelihood ratio of 0.06. The only case with DST≥1.8 and ACTH≥20 had Cushing′s phenotype with both an adrenal adenoma and a pituitary ACTH-producing adenoma. Systematic evaluation of morning cortisol and ACTH allowed the detection of 5 cases of false negative low DST values due to the use of non-oral corticosteroids. Conclusion: In this cohort, an ACTH ≥20pg/ml excluded autonomous cortisol secretion with excellent sensitivity and negative predictive value, providing strong reassurance that there is no clinically relevant hypercortisolism. Therefore, subjects with a normal DST and ACTH ≥20pg/ml should be candidates for relaxed surveillance. Oxford University Press 2020-05-08 /pmc/articles/PMC7207414/ http://dx.doi.org/10.1210/jendso/bvaa046.1308 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Adrenal
Olmos, Roberto Ignacio
Macchiavello, Stefano Pietro
Vaidya, Anand
Robles, Consuelo
Gutierrez, Javiera
Guarda, Francisco J
Francisco, Ignacio San
Huete, Alvaro
Baudrand, Rene
OR25-06 Morning ACTH Levels as a Reliable Biomarker for Excluding Autonomous Cortisol Secretion in Incidetally Discovered Adrenal Adenomas. A Prospective Cohort
title OR25-06 Morning ACTH Levels as a Reliable Biomarker for Excluding Autonomous Cortisol Secretion in Incidetally Discovered Adrenal Adenomas. A Prospective Cohort
title_full OR25-06 Morning ACTH Levels as a Reliable Biomarker for Excluding Autonomous Cortisol Secretion in Incidetally Discovered Adrenal Adenomas. A Prospective Cohort
title_fullStr OR25-06 Morning ACTH Levels as a Reliable Biomarker for Excluding Autonomous Cortisol Secretion in Incidetally Discovered Adrenal Adenomas. A Prospective Cohort
title_full_unstemmed OR25-06 Morning ACTH Levels as a Reliable Biomarker for Excluding Autonomous Cortisol Secretion in Incidetally Discovered Adrenal Adenomas. A Prospective Cohort
title_short OR25-06 Morning ACTH Levels as a Reliable Biomarker for Excluding Autonomous Cortisol Secretion in Incidetally Discovered Adrenal Adenomas. A Prospective Cohort
title_sort or25-06 morning acth levels as a reliable biomarker for excluding autonomous cortisol secretion in incidetally discovered adrenal adenomas. a prospective cohort
topic Adrenal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207414/
http://dx.doi.org/10.1210/jendso/bvaa046.1308
work_keys_str_mv AT olmosrobertoignacio or2506morningacthlevelsasareliablebiomarkerforexcludingautonomouscortisolsecretioninincidetallydiscoveredadrenaladenomasaprospectivecohort
AT macchiavellostefanopietro or2506morningacthlevelsasareliablebiomarkerforexcludingautonomouscortisolsecretioninincidetallydiscoveredadrenaladenomasaprospectivecohort
AT vaidyaanand or2506morningacthlevelsasareliablebiomarkerforexcludingautonomouscortisolsecretioninincidetallydiscoveredadrenaladenomasaprospectivecohort
AT roblesconsuelo or2506morningacthlevelsasareliablebiomarkerforexcludingautonomouscortisolsecretioninincidetallydiscoveredadrenaladenomasaprospectivecohort
AT gutierrezjaviera or2506morningacthlevelsasareliablebiomarkerforexcludingautonomouscortisolsecretioninincidetallydiscoveredadrenaladenomasaprospectivecohort
AT guardafranciscoj or2506morningacthlevelsasareliablebiomarkerforexcludingautonomouscortisolsecretioninincidetallydiscoveredadrenaladenomasaprospectivecohort
AT franciscoignaciosan or2506morningacthlevelsasareliablebiomarkerforexcludingautonomouscortisolsecretioninincidetallydiscoveredadrenaladenomasaprospectivecohort
AT huetealvaro or2506morningacthlevelsasareliablebiomarkerforexcludingautonomouscortisolsecretioninincidetallydiscoveredadrenaladenomasaprospectivecohort
AT baudrandrene or2506morningacthlevelsasareliablebiomarkerforexcludingautonomouscortisolsecretioninincidetallydiscoveredadrenaladenomasaprospectivecohort